Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Sarah Gheuens

Chief Medical Officer at Agios Pharmaceuticals, Inc. (AGIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 6SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 30,00054,645 held (−35%) $30.48 $914K +4.4%
Jul 2SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 4,00784,645 held (−5%) $37.56 $151K -15.3%
Apr 6SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 2,94080,277 held (−4%) $34.71 $102K -8.4%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 1,18767,608 held (−2%) $28.96 $34K +9.8%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 1,68171,593 held (−2%) $28.96 $49K +9.8%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 1,18774,406 held (−2%) $28.96 $34K +9.8%
Jan 2SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 2,93264,795 held (−4%) $27.09 $79K +17.4%
Nov 13SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 2,45461,727 held (−4%) $43.78 $107K -27.3%
Nov 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 20061,727 held (−0%) $43.81 $9K -27.4%
Oct 29SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 3,30261,727 held (−5%) $43.92 $145K -27.6%
  • Sell

    Chief Medical Officer Sarah Gheuens sold $914K of AGIO at $30.48 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Sarah Gheuens sold $151K of AGIO at $37.56 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Sarah Gheuens sold $102K of AGIO at $34.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Sarah Gheuens sold $34K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Sarah Gheuens sold $49K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Sarah Gheuens sold $34K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.